Key Highlights

  • Abbott Laboratories (NYSE:ABT) pays USD 0.63 per share, with an ex-dividend date of October 15, a payment date of November 16 and a screen yield of 2.46%.
  • Abbott goes ex-dividend on October 15 for a USD 0.63 per share quarterly dividend payable November 16, an annual rate of USD 2.52, and has raised its payout for 54 consecutive years.
  • The 2026 dividend is 6.8% above the USD 0.59 paid in 2025, adjusted EPS guidance is USD 5.45 to USD 5.60 and third-quarter guidance is USD 1.38 to USD 1.46.
  • Third-quarter results are due October 21 before the open, the Exact Sciences acquisition dilutes 2026 EPS by about USD 0.20, and the USD 2.52 dividend is about 46% of guided EPS.

Dividend Details and Latest Updates

Abbott Laboratories goes ex-dividend on October 15 for a quarterly dividend of USD 0.63 per share, payable on November 16, and the board has increased its dividend payout for 54 consecutive years, making it a Dividend Aristocrat. The 2026 quarterly dividend of USD 0.63 is 6.8% above the USD 0.59 declared in each of the first two quarters of 2025. Abbott will report third-quarter results on October 21 before the market opens, with a call at 8 a.m. central time.

Coverage, Yield and the Data

Full-year 2026 adjusted EPS guidance is USD 5.45 to USD 5.60, third-quarter adjusted EPS guidance is USD 1.38 to USD 1.46, and the acquisition of Exact Sciences dilutes 2026 EPS by about USD 0.20. The USD 2.52 annual dividend is about 46% of the USD 5.53 guidance midpoint, simple arithmetic, and the company repurchased about 11.6 million shares for USD 1.0 billion in the first half. Second-quarter EPS was USD 1.31 versus USD 1.28 expected on revenue of USD 12.59 billion, up 13.0%, and the screen's 2.46% yield implies a price near USD 102.44. The payout goes ex-dividend on October 15 and is paid 32 days later on November 16, so only holders who own the shares before the ex-date receive it. Annualized at 4 payments the dividend is USD 2.52, and the screen's yield of 2.46% implies a share price near USD 102.44, simple arithmetic. Each USD 0.63 payment equals about 0.61% of that implied price, which is roughly how far the stock may adjust on the ex-date.

Risks and What to Watch

Diagnostics demand swings, acquisition dilution and currency effects can affect earnings guidance. What to watch next: the October 21 results, guidance and the dividend increase in December. This is information only and not investment advice. The ex-dividend date is the first day a buyer no longer receives the declared payout, and a stock price typically adjusts down by roughly the dividend amount on that day. September CPI came in hotter than expected on October 14, the 10-year Treasury yield rose to about 5.28% and investors worry the Fed could raise rates on October 27 and 28.

Where Things Stand

Dividend investors should weigh yield against coverage, because a high yield can signal market doubt as easily as value. Abbott Laboratories (NYSE:ABT) is in focus because of a long dividend streak backed by moderate payout. An ex-dividend date is mechanical, so the share price typically adjusts down by about the payout, and the balance of evidence favors checking coverage before acting. Direction remains unknown, and the next catalyst is the October 21 results, guidance and the dividend increase in December. Check the underlying filings first, verify the latest filings before acting, and treat the figures as a snapshot.